Selectchemie AG
Dr. Markus Kunze serves as the Director of Quality Management & Regulatory Affairs at Selectchemie AG since January 2019, where responsibilities include functioning as a Qualified Person (FvP), leading agile team transformations, optimizing processes, and initiating a Corporate Social Responsibility concept. Prior experience includes roles at Acino Pharma AG, where Dr. Kunze held positions such as Head of Global Regulatory Affairs & Strategy, overseeing global regulatory teams and submissions, and Senior DRA Manager, managing regulatory country operations across multiple regions. Earlier, Dr. Kunze was a Global Evaluation Manager at Sandoz, focusing on harmonization and cost-saving initiatives, and held positions in regulatory affairs at Hexal AG. Dr. Kunze holds a Diploma in Chemistry from Bergische Universität Wuppertal, completing studies there from 1990-2002.
This person is not in any teams
Selectchemie AG
1 followers
Selectchemie is an independent Swiss company serving the pharmaceutical and nutrition industry since 1969 as a premier supplier of high quality ingredients and generic finished dosage forms. Worldwide, our 120 experienced professionals with commercial and scientific background provide customers, principals and suppliers with solutions tailored to their needs. With 70 employees based at the company headquarters in Zurich, we are still deeply connected to our Swiss roots. At the same time our global network with locations in 18 countries allows us to be as close to our customers as possible, as their individual needs are our main focus. We offer a wide range of selected raw materials for all kinds of pharmaceutical and nutrition products and create added value for our customers by providing comprehensive technical, scientific, regulatory and commercial support all along the value chain.